Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 16, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print November 16, 2006, doi: 10.1161/01.ATV.0000252842.57585.df
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/2/332    most recent
01.ATV.0000252842.57585.dfv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimman, A.
Right arrow Articles by Berliner, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimman, A.
Right arrow Articles by Berliner, J. A.

Submitted on July 14, 2006
Accepted on October 27, 2006

Vascular Endothelial Growth Factor Receptor 2 Plays a Role in the Activation of Aortic Endothelial Cells by Oxidized Phospholipids

Alejandro Zimman ; Kevin P. Mouillesseaux ; Thang Le ; Nima M. Gharavi ; Ann Ryvkin ; Thomas G. Graeber ; Tom T. Chen ; Andrew D. Watson ; and Judith A. Berliner *

From the Departments of Medicine (A.Z., K.P.M., T.L., N.M.G., J.A.B.), Pathology (A.Z., K.P.M., T.L., N.M.G., J.A.B.), Molecular & Medical Pharmacology (A.R., T.G.G.), Crump Institute for Molecular Imaging (T.G.G.), Cardiology (A.D.W.), and the Molecular Biology Institute (T.T.C.), University of California, Los Angeles.

* To whom correspondence should be addressed. E-mail: jberliner{at}mednet.ucla.edu.

Objective--Previous studies have shown that oxidized products of PAPC (Ox-PAPC) regulate cell transcription of interleukin-8, LDL receptor, and tissue factor. This upregulation takes place in part through the activation of sterol regulatory element-binding protein (SREBP) and Erk 1/2. The present studies identify vascular endothelial growth factor receptor 2 (VEGFR2) as a major regulator in the activation of SREBP and Erk 1/2 in endothelial cells activated by Ox-PAPC.

Methods and Results--Ox-PAPC induced the phosphorylation of VEGFR2 at Tyr1175 in human aortic endothelial cells. Inhibitors and siRNA for VEGFR2 decreased the transcription of interleukin-8, LDL receptor, and tissue factor in response to Ox-PAPC and the activation of SREBP and Erk 1/2, which mediate this transcription. We provide evidence that the activation of VEGFR2 is rapid, sustained, and c-Src-dependent.

Conclusions--These data point to a major role of VEGFR2 in endothelial regulation by oxidized phospholipids which accumulate in atherosclerotic lesions and apoptotic cells.




This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
J. A. Berliner, N. Leitinger, and S. Tsimikas
The role of oxidized phospholipids in atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S207 - S212.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Lee, R. Li, B. Kim, R. Palvolgyi, T. Ho, Q.-Z. Yang, J. Xu, W. L. Szeto, H. Honda, and J. A. Berliner
Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell
J. Lipid Res., February 1, 2009; 50(2): 265 - 274.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.